Edgewise Therapeutics Stock Forecast

Buy candidate since Jul 17, 2026

The Edgewise Therapeutics, Inc. stock price gained 4.11% on the last trading day (Friday, 17th Jul 2026), rising from $38.19 to $39.76. During the last trading day the stock fluctuated 8.57% from a day low at $37.21 to a day high of $40.40. The price has risen in 6 of the last 10 days and is up by 0.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 54 thousand more shares were traded than the day before. In total, 730 thousand shares were bought and sold for approximately $29.03 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $37.53 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 29.45% during the next 3 months and, with a 90% probability hold a price between $48.59 and $64.02 at the end of this 3-month period.

EWTX Signals & Forecast

The Edgewise Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $41.93. On a fall, the stock will find some support from the long-term average at approximately $38.56. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -17.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Edgewise Therapeutics, Inc. stock

Edgewise Therapeutics, Inc. finds support from accumulated volume at $38.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.19 between high and low, or 8.57%. For the last week, the stock has had daily average volatility of 7.74%.

Our recommended stop-loss: $37.35 (-6.06%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (EWTX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Edgewise Therapeutics, Inc. to open at $39.12, and during the day (based on 14 day Average True Range), to move between $38.39 and $41.13, which gives a possible trading interval of +/-$2.74 (+/-7.15%) up or down from last closing price. If Edgewise Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $40.26 (1.26%) than the support at $38.01 (4.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Edgewise Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Edgewise Therapeutics, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 1.930 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $39.12 ( 1.60%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk